In vitro studies by Ogata et al.43 showed that CEA produced by colorectal cancer cells is highly correlated with tumor resistance to lymphokine-activated killer (LAK) cells by inhibiting cytolysis, LAK cell infiltration, and LAK cell adherence to colorectal cancer cells. The gene discussed is CEACAM5; the disease is colorectal cancer.